CHAM
EPZM

Clear Harbor Asset Management’s Epizyme, Inc EPZM Stock Holding History

Clear Harbor Asset Management’s Portfolio EPZM Stock Details EPZM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-700
Closed -$8.35K – 784
2020
Q3 		$8.35K Buy
+700
New +$9.38K ﹤0.01% 611
2020
Q1 		– Sell
-700
Closed -$17.2K – 751
2019
Q4 		$17.2K Buy
+700
New +$10.4K ﹤0.01% 544

Other funds holding EPZM

Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
RM
RP Management New York $139M AUM 37.98% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
KXA
KPCB XIII Associates Menlo Park, California $186M AUM 11.23% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $2.05B AUM 161.37% 1-Year Est. Return

Clear Harbor Asset Management's EPZM Position: Q4 2020 in Review

Clear Harbor Asset Management sold out of Epizyme, Inc (EPZM) in Q4 2020, closing a stake of 700 shares — an estimated $8.35K sold.

Clear Harbor Asset Management first reported a position in EPZM in Q4 2019 and held it in 2 quarters. The position peaked at $17.2K in Q4 2019. 138 funds tracked by Wall St. Rank hold EPZM as of Q4 2020.

  • Clear Harbor Asset Management reported no remaining Epizyme, Inc position as of Q4 2020 after selling out during the quarter.
  • Clear Harbor Asset Management sold 700 Epizyme, Inc shares in Q4 2020, an estimated $8.35K.
  • Clear Harbor Asset Management first reported a position in Epizyme, Inc in Q4 2019 and held it in 2 quarters.
  • Clear Harbor Asset Management's Epizyme, Inc position peaked at $17.2K in Q4 2019.
  • 138 funds tracked by Wall St. Rank held Epizyme, Inc as of Q4 2020.

Based on Clear Harbor Asset Management's 13F filing for Q4 2020, filed 4 Feb 2021.